KPIs & Operating Metrics(New)
Growth Metrics

Chemed (CHE) Share-based Compensation (2016 - 2026)

Chemed filings provide 18 years of Share-based Compensation readings, the most recent being $9.2 million for Q1 2026.

  • For the quarter ending Q1 2026, Share-based Compensation rose 1.74% year-over-year to $9.2 million, compared with a TTM value of $1.3 million through Mar 2026, down 96.01%, and an annual FY2025 reading of $1.1 million, down 96.49% over the prior year.
  • Share-based Compensation hit $9.2 million in Q1 2026 for Chemed, up from -$23.3 million in the prior quarter.
  • The five-year high for Share-based Compensation was $30.8 million in Q4 2024, with the low at -$23.3 million in Q4 2025.
  • Median Share-based Compensation over the past 5 years was $8.4 million (2023), compared with a mean of $4.3 million.
  • The largest YoY upside for Share-based Compensation was 299.05% in 2024 against a maximum downside of 402.38% in 2024.
  • Year by year, Share-based Compensation stood at -$18.2 million in 2022, then skyrocketed by 142.4% to $7.7 million in 2023, then skyrocketed by 299.05% to $30.8 million in 2024, then plummeted by 175.61% to -$23.3 million in 2025, then skyrocketed by 139.78% to $9.2 million in 2026.
  • According to Business Quant data, Share-based Compensation over the past three periods came in at $9.2 million, -$23.3 million, and $6.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.